European meeting of ISMPP 2021

Share this page
Share this page on LinkedIn

Collaboration, connectivity and change

quote-left

ISMPP is a fantastic opportunity to share best practice and connect with people who share our vision for what medical publications and communications can achieve.

Chris Winchester, CEO

quote-right

Poster list

How openly accessible is pharma-sponsored research? An informatics approach

Harry Freeman, Steph Macdonald, Slavka Baronikova (Galapagos), Lara Miller (Alexion), Valérie Philippon (Takeda), Tim Koder and Tom Rees

Improving the use of ORCID: a publisher case study

Laura Dormer (FSG), Sarah Sabir, Joanne Walker (FSG) and Paul Farrow

9A4369E7-439B-4AEC-A9E8-6B36DB531786

QRdb

QRdb, from Oxford PharmaGenesis, is a secure, adaptable, online content management system designed to deliver electronic versions of congress posters/presentations alongside their supplementary information, such as plain language summaries, podcasts, videos/animations, and other media. It can be run as a fully managed service by us, by you and/or your agencies without our involvement, or with additional support and training.

Poster list

Podcasts for delivery of medical education

Julliana Newman (Gilead), Andrew Liew, Jon Bowles, Kelly Soady and Steven Inglis)

Analysis of pharmaceutical industry-affiliated preprints in the medRxiv repository

Susan Wieting (Takeda), Sunita Setlur (Takeda), Ericka Bueno (Takeda), Nicolas Bertheleme, Kim Wager, and Valérie Philippon (Takeda)

Authorship practices for publications affiliated to a mid-sized pharmaceutical company

Heather Lang, Laura Drought, Phoebe Hobbs, William T Gattrell (Ipsen)

Tool to measure real-world publication reach, engagement and impact

Tom Rees, Heather Lang, and William T Gattrell (Ipsen)

What makes us an award-winning HealthScience communications consultancy?

Our services are transformative: we're experts in publications, medical affairs, informatics and patient engagement. Our people are extraordinary: we help clients to bring new treatments to the world in areas of unmet medical need. Our vision is powerful: we're shaping the future through transparent and accessible research.